Skip to main content

Table 1 Patient characteristics at randomization

From: Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial

 

24 h Magnesium Sulphate

6 h Magnesium Sulphate

p value

Post Delivery Group

Post Delivery Group

N = 143

N = 141

Hypertensive disorder N (%)

 Severe Preeclampsia

115 (80.5)

116 (82.3)

0.68

 Superimposed preeclampsiaa

28 (19.5)

25 (17.7)

 

Age - SD (year)

28.3 ± 7.5

28.7 ± 6.8

0.65

Parity

2.2 (1.6)

2.5 (1.7)

0.23

Mean Gestational Age (weeks)

36.2 (2.8)

36.1 (3.1)

0.73

Symptomsb n (%)

88 (61.5)

86 (61)

0.92

SBP mmHg, Mean (SD)

155.2 ± 13.1

158.0 ± 17.1

0.24

DBP mmHg, Mean (SD)

100.0 ± 8.9

102.3 ± 10.8

0.14

Hours with magnesium sulfate after loading dose to birth h (SD)

4.6 (2.3)

3.9 (3.8)

0.32

Cesarean Section, N (%)

92 (64.3)

96 (68.0)

0.50

  1. aChronic blood pressure with severe features of superimposed preeclampsia
  2. bOne or more symptoms: Severe headache, visual disturbances, epigastric pain